I mercati dell'Italia hanno chiuso

ZNTL Oct 2024 2.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,45000,0000 (0,00%)
Alla chiusura: 03:42PM EDT
Schermo intero
Chiusura precedente1,4500
Aperto1,6800
Denaro0,0000
Domanda2,1500
Prezzo d'esercizio2,50
Scadenza2024-10-18
Min-Max giorno1,4500 - 1,6800
Contratto - Min-MaxN/D
Volume2
Open Interest44
  • GlobeNewswire

    Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    NEW YORK and SAN DIEGO, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancer, today announced that on October 2, 2023, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 101,375 shares of the Company’s common stock to four